AI Article Synopsis

  • The study investigated clinical outcomes for cervical cancer patients experiencing isolated pelvic failures after radiation treatment, analyzing data from a tertiary center between 1997 and 2016.
  • Out of 607 patients, 67 (11%) had isolated pelvic failures, with a median recurrence time of 9 months and various treatment pathways including surgery, chemotherapy, or no treatment.
  • Patients with FDG-avid pelvic and para-aortic nodes at initial diagnosis had poorer distant control, and those who underwent surgical salvage had better overall survival compared to those who didn't receive surgery or chemotherapy.

Article Abstract

Purpose: To describe clinical outcomes in patients with isolated pelvic failures after definitive radiation treatment for cervical cancer.

Methods And Materials: Cervical cancer patients with isolated pelvic failure after definitive radiation with brachytherapy boost were identified in a tertiary academic center database from 1997 to 2016. All patients received an FDG-PET scan prior to their initial treatment and at the time of their first recurrence. Isolated failures in the cervix or pelvic nodes were biopsy-proven. Distant failure and overall survival (OS) were censored outcomes.

Results: Isolated pelvic failure was detected in 67(11%) out of 607 consecutive patients treated with external beam pelvic radiation and brachytherapy boost. The median time to isolated pelvic recurrence was 9 months (range 3-198). Median follow-up time for patients alive after isolated pelvic recurrence was 40 months (range 0.6-183). Of these 67 patients, 28(42%) received salvage surgery, 17(25%) received chemotherapy alone, and 22(33%) received neither surgery nor chemotherapy. The median time to distant failure after isolated pelvic failure was 20 months (95% CI 3-37), with no significant difference between patients treated surgically vs. non-surgically. FDG-avid pelvic and para-aortic nodes at initial presentation were associated with worse distant control after isolated pelvic failure (HR = 3.4, 95% CI 1.0-12). Median OS for patients treated with surgery, chemotherapy alone, and neither surgery nor chemotherapy was 29 months (95% CI 16-41), 12 months (95% CI 3-21), and 3 months (95% CI 1-5), respectively.

Conclusions: Patients who have pelvic and para-aortic nodal disease at initial presentation are at higher risk of failing distantly after isolated pelvic failure, which should be considered when counseling patients on aggressive surgical salvage. Surgical salvage was associated with prolonged survival after isolated pelvic failure.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428083PMC
http://dx.doi.org/10.1016/j.ygyno.2019.03.104DOI Listing

Publication Analysis

Top Keywords

isolated pelvic
40
pelvic failure
28
patients treated
16
pelvic
14
definitive radiation
12
surgery chemotherapy
12
isolated
11
patients
11
failure
9
clinical outcomes
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!